USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facility
Summary
Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, ...
Description
Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source